Navigating the Business of Biopharma - Insights from Biopharma Boardroom

25 September, 2023 | Monday

GSK is first to ship influenza vaccine doses for the 2023-24 flu season in US

GSK plc (LSE/NYSE: GSK) today announced it has started shipping doses of its quadrivalent influenza vaccines to US healthcare providers and pharmacies in p...

July 14, 2023 | Friday | News

CSafe Providing Sustainable Thermal Protection for Vyjuvek Gene Therapy from Krystal Biotech

CSafe's custom thermal shipper for Krystal maintains -20°C throughout the product journey to help ensure that doses of Vyjuvek reach clinicians and pat...

May 22, 2023 | Monday | News

Tower Cold Chain partnership expands Saudi Cargo's options for shipping pharmaceuticals in the Middle East.

Saudia Cargo has added Tower Cold Chain to its approved roster of temperature-controlled containers for shipping pharmaceutical, biotech and life science p...

April 18, 2023 | Tuesday | News

Cathay Cargo partners with Tower Cold Chain for global pharma logistics solutions

Ideal for the transportation of life-saving pharmaceutical, biotech and life-science products, Tower’s robust, reliable, reusable solutions are a wel...

April 01, 2023 | Saturday | News

Partner Content

Autophagy Signaling Pathways: Therapeutic Targets for Neurodegenerative Diseases
27 July, 2023
Redefining precision medicine with real-time insights
18 July, 2023
Radioligand Binding Assays: From Opiate Receptors to Drug Discovery Mainstay
04 July, 2023
Looking for [Process] Validation in All the Right Places
04 July, 2023
Mass Spectrometry Explained: 5 Application Areas for LC/MS/MS
22 June, 2023
Challenges and strategies for characterization of next-generation bispecific antibodies
22 June, 2023
Illuminating Cancer Research: What Tumor Burden Alone Can’t Tell You
22 June, 2023

BioPharma BreakThrough's

Editor Picks

WuXi XDC and Boostimmune Sign MOU for Integrated Services
11 August, 2023
Imperative Care Unveils New Structure to Elevate Care for Patients with Vascular Diseases
11 August, 2023
Boston Scientific Receives FDA Approval for the POLARx™ Cryoablation System
09 August, 2023
FDA Approves First Oral Treatment for Postpartum Depression
07 August, 2023
Bavarian Nordic's Chikungunya Vaccine Shows Positive Phase 3 Results in Adults and Adolescents
07 August, 2023
Etiometry's AI Algorithm FDA Cleared to Alert Neonatal Hypercapnia Risk
03 August, 2023
Molecular Targeting Technologies and Singapore's Theranostics Center Gain HSA Approval for EBTATE® Trial in Nasopharyngeal Cancer
03 August, 2023

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

Gene Editing Breakthroughs

Innovative Drug Discovery

Vaccine Development

Biologics and Therapeutic Antibodies

× Please select an option to participate in the poll.

View poll results More polls

× You have successfully cast your vote.

{{ optionDetail.option }} {{ optionDetail.percentage }}%

More polls

About Us Media Pack Contact Us Privacy Policy

© 2023 Biopharma Boardroom. All Rights Reserved.